Friday, October 11, 2024
Home Oncology & Cancer Quality-of-life outcomes reported from trial comparing whole-breast and partial-breast irradiation post-surgery

Quality-of-life outcomes reported from trial comparing whole-breast and partial-breast irradiation post-surgery

by Medical Xpress
0 comment


Credit: Unsplash/CC0 Public Domain

The NRG Oncology (NRG)/NSABP B-39/RTOG 0413 clinical trial compared whole-breast irradiation (WBI) to accelerated partial-breast irradiation (APBI) and determined that APBI was not statistically equivalent to WBI in local tumor control. The secondary outcome for the trial was Quality-of-life (QOL).

The research is published in the JNCI: Journal of the National Cancer Institute.

The study enrolled 4,210 patients with Stage 0, I, or II resected by lumpectomy; ≤ 3.0 cm; and no more than 3 histologically positive nodes with the primary aim to determine whether (PBI) limited to the region of the tumor bed following lumpectomy provided equivalent local tumor control in the breast compared to conventional whole breast irradiation (WBI) in the local management of early stage breast cancer.

The QOL sub-study provided an in-depth evaluation of fatigue and treatment toxicities using well-established patient-reported-outcomes measures. With a target accrual of 964 patients (482 with clinician intent to prescribe chemotherapy and 482 without), the QOL sub-study used validated including the Breast Cancer Treatment Outcome Scale (BCTOS) and the SF-36 vitality scale.

Assessments occurred before randomization, at completion of chemotherapy or radiotherapy, 4-weeks later, and at 6-, 12-, 24-, and 36-months. The primary aims for the QOL sub-study were cosmesis change equivalency and fatigue change superiority for APBI vs. WBI, according to patient groups treated with or without chemotherapy.

Cosmetic outcomes were similar for APBI and WBI groups, with small statistically significant differences in other outcomes that varied over time. Differences in fatigue and other symptoms appeared to resolve by ≥6 months. APBI may be preferred by some patients, for whom extended treatment is burdensome.

“Partial- and whole-breast radiation have equivalent at 3 years post-lumpectomy in breast cancer patients, but significantly greater end-of-treatment fatigue occurred in patients receiving whole breast irradiation after lumpectomy without chemotherapy,” stated Patricia Ganz, MD, of the University of California Los Angeles, and Behavioral and Health Outcomes Officer for the trial.

More information:
Patricia A Ganz et al, Quality-of-Life Outcomes from NRG/NSABP B-39/RTOG 0413: Whole-breast Irradiation vs Accelerated Partial-breast Irradiation after Breast Conserving Surgery, JNCI: Journal of the National Cancer Institute (2024). DOI: 10.1093/jnci/djae219

Provided by
NRG Oncology

Citation:
Quality-of-life outcomes reported from trial comparing whole-breast and partial-breast irradiation post-surgery (2024, September 16)
retrieved 16 September 2024
from https://medicalxpress.com/news/2024-09-quality-life-outcomes-trial-breast.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.





Source link

You may also like

Leave a Comment

Edtior's Picks

Latest Articles

All Rights reserved, site designed by Yellohost.co.za